Dr. Stupp Discusses Results from the EF-14 Trial

Adding TTFields to Chemotherapy to Improve Survival in GlioblastomaПодробнее

Dr. de Groot Discusses Altiratinib as Potential Treatment for GlioblastomaПодробнее

Dr. Strosberg Discusses Results for KEYNOTE-158Подробнее

Dr. Rugo on SWISH Trial for HR-Positive Breast CancerПодробнее

Dr. Martin van den Bent Discusses the BELOB TrialПодробнее

Investigating TTFields for Treatment of Newly Diagnosed GlioblastomaПодробнее

Dr. Roger Stupp on Tumor-Treating Fields and Tumor Growth PatternsПодробнее

Dr. Stupp on Final Results for TTFields Added to Chemo in GlioblastomaПодробнее

Dr. Strosberg Discusses Results for KEYNOTE-158Подробнее

Dr. Reardon Discusses the ReACT StudyПодробнее

Chang: Temozolomide vs. Nitrosourea for Anaplastic AstrocytomaПодробнее

Dr. Seymour Discusses the Results of the PRIMA StudyПодробнее

Dr. Loibl Discusses GeparSepto Trial in Breast CancerПодробнее

Second Interim Analysis from a Phase III Trial on Concurrent and Adjuvant Temozolomide for...Подробнее

Dr. Sequist on Rationale for TATTON Trial in EGFR-Mutant Lung CancerПодробнее

Dr. van den Bent on Concurrent and Adjuvant Temozolomide in Anaplastic GliomaПодробнее

Elderly patients with glioblastoma live longer with chemoradiation using temozolomideПодробнее

WFNS YNF Webinar - The Stupp Protocol with Dr. Stupp himselfПодробнее

Hear from Gregg Nelson, MD, PhD, about Upcoming HIPEC WebinarПодробнее